SEC Comment Letter 0000000000-24-012636 to Mural Oncology plc (MURA) (CIK 0001971543)
Mural Oncology plc (MURA) (CIK 0001971543)
Date: Nov. 14, 2024 · CIK: 0001971543 · Accession: 0000000000-24-012636
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283198
Letter
November 14, 2024 Caroline Loew Chief Executive Officer Mural Oncology plc 10 Earlsfort Terrace Dublin 2, D02 T380, Ireland Re:Mural Oncology plc Registration Statement on Form S-3 Filed November 13, 2024 File No. 333-283198 Dear Caroline Loew: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Scott N. Lunin, Esq.
Show Raw Text
November 14, 2024
Caroline Loew
Chief Executive Officer
Mural Oncology plc
10 Earlsfort Terrace
Dublin 2, D02 T380, Ireland
Re:Mural Oncology plc
Registration Statement on Form S-3
Filed November 13, 2024
File No. 333-283198
Dear Caroline Loew:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Scott N. Lunin, Esq.